FGFR4 and neoplasm: They were also incorporated into targeted liposomal drug delivery systems for FGFR4-positive RMS and used to generate chimeric antigen receptor (CAR) T cells that displayed potent cytotoxicity against FGFR4-expressing tumor cells [144].